Literature DB >> 15251069

Massively parallel signature sequencing (MPSS) as a tool for in-depth quantitative gene expression profiling in all organisms.

Jeanette Reinartz1, Eddy Bruyns, Jing-Zhong Lin, Tim Burcham, Sydney Brenner, Ben Bowen, Michael Kramer, Rick Woychik.   

Abstract

Massively parallel signature sequencing (MPSS) is one of the newest tools available for conducting in-depth expression profiling. MPSS is an open-ended platform that analyses the level of expression of virtually all genes in a sample by counting the number of individual mRNA molecules produced from each gene. There is no requirement that genes be identified and characterised prior to conducting an experiment. MPSS has a routine sensitivity at a level of a few molecules of mRNA per cell, and the datasets are in a digital format that simplifies the management and analysis of the data. Therefore, of the various microarray and non-microarray technologies currently available, MPSS provides many advantages for generating the type of complete datasets that will help to facilitate hypothesis-driven experiments in the era of digital biology.

Mesh:

Substances:

Year:  2002        PMID: 15251069     DOI: 10.1093/bfgp/1.1.95

Source DB:  PubMed          Journal:  Brief Funct Genomic Proteomic        ISSN: 1473-9550


  32 in total

Review 1.  Platelet genomics and proteomics in human health and disease.

Authors:  Iain C Macaulay; Philippa Carr; Arief Gusnanto; Willem H Ouwehand; Des Fitzgerald; Nicholas A Watkins
Journal:  J Clin Invest       Date:  2005-12       Impact factor: 14.808

2.  Evolutionary fate of retroposed gene copies in the human genome.

Authors:  Nicolas Vinckenbosch; Isabelle Dupanloup; Henrik Kaessmann
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-21       Impact factor: 11.205

3.  Genome-wide allele-specific expression analysis using Massively Parallel Signature Sequencing (MPSS) reveals cis- and trans-effects on gene expression in maize hybrid meristem tissue.

Authors:  Mei Guo; Sean Yang; Mary Rupe; Bin Hu; David R Bickel; Lane Arthur; Oscar Smith
Journal:  Plant Mol Biol       Date:  2008-01-26       Impact factor: 4.076

4.  Deep sequencing maps the maize epigenomic landscape.

Authors:  Nancy A Eckardt
Journal:  Plant Cell       Date:  2009-04       Impact factor: 11.277

5.  Inference of isoforms from short sequence reads.

Authors:  Jianxing Feng; Wei Li; Tao Jiang
Journal:  J Comput Biol       Date:  2011-03       Impact factor: 1.479

6.  Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma.

Authors:  Rossa W K Chiu; K C Allen Chan; Yuan Gao; Virginia Y M Lau; Wenli Zheng; Tak Y Leung; Chris H F Foo; Bin Xie; Nancy B Y Tsui; Fiona M F Lun; Benny C Y Zee; Tze K Lau; Charles R Cantor; Y M Dennis Lo
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-10       Impact factor: 11.205

7.  Alternative polyadenylation in glioblastoma multiforme and changes in predicted RNA binding protein profiles.

Authors:  Jiaofang Shao; Jing Zhang; Zengming Zhang; Huawei Jiang; Xiaoyan Lou; Bingding Huang; Gregory Foltz; Qing Lan; Qiang Huang; Biaoyang Lin
Journal:  OMICS       Date:  2013-02-19

Review 8.  Global expression profiling in epileptogenesis: does it add to the confusion?

Authors:  Yi Yuen Wang; Paul Smith; Michael Murphy; Mark Cook
Journal:  Brain Pathol       Date:  2009-02-24       Impact factor: 6.508

9.  A myriad of miRNA variants in control and Huntington's disease brain regions detected by massively parallel sequencing.

Authors:  Eulàlia Martí; Lorena Pantano; Mónica Bañez-Coronel; Franc Llorens; Elena Miñones-Moyano; Sílvia Porta; Lauro Sumoy; Isidre Ferrer; Xavier Estivill
Journal:  Nucleic Acids Res       Date:  2010-06-30       Impact factor: 16.971

10.  SeqBuster, a bioinformatic tool for the processing and analysis of small RNAs datasets, reveals ubiquitous miRNA modifications in human embryonic cells.

Authors:  Lorena Pantano; Xavier Estivill; Eulàlia Martí
Journal:  Nucleic Acids Res       Date:  2009-12-11       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.